Angela Calman shares how working at 23andMe shaped her perspective on genetic testing before she learned she carries two copies of the APOE4 gene, a variant associated with increased Alzheimer's risk. Rather than viewing the result as a prediction, she saw it as an opportunity to improve her health through diet, exercise, and other lifestyle changes. She also reflects on her parents' very different experiences with Alzheimer's, illustrating how early detection and lifelong health habits can influence the course of cognitive decline.

The conversation also highlights the enormous financial burden of late-stage dementia, with residential memory care often costing well over $10,000 per month. Calman argues that earlier diagnosis benefits not only patients and families but society as a whole by creating opportunities for prevention, planning, and intervention before the disease progresses.

https://aheadofalzheimers.org/ep-8-angela-calman-the-power-of-genetic-data/